相关实验视频

Updated: Jun 28, 2025

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

代理程序在解码TORC1活动时引入了偏差

Marco Caligaris¹, Claudio De Virgilio¹

¹Department of Biology, University of Fribourg, Fribourg, Fribourg, Switzerland.

microPublication biology

|April 12, 2024

概括

测量mTORC1激酶的活性需要仔细选择目标蛋白. 不同的点,如酵母中的Sch9和Rps6,显示出不同的酸化模式,揭示了评估mtORC1活动的偏差.

科学领域:

分子生物学分子生物学
细胞生物学细胞生物学
生物化学生物化学

背景情况:

拉巴胺素复合物1 (mTORC1) 激酶的机械性标是细胞生长,新陈代谢和恒温的中心调节者.
mTORC1集成了各种信号,包括营养素,能量状态和生长因素.
mTORC1信号失调与各种人类疾病有关,如癌症,神经退行症和代谢障碍.

研究的目的:

调查用于量化酵母中mTORC1活性的常用下游目标的可靠性.
为了确定不同的mTORC1效应器在不同的条件下是否提供一致的激酶活性读数.

主要方法:

使用酵母 (Saccharomyces cerevisiae) 作为一个模型生物体.
评估了两个关键mTORC1目标的酸化状态:Sch9和核糖体蛋白S6 (Rps6).
通过拉帕治疗操纵细胞状况并改变的可用性.

主要成果:

Sch9和Rps6在响应拉帕米辛治疗时表现出不同的酸化模式.
当的可用性发生变化时,对Sch9和Rps6观察到不同的酸化概况.
这些发现表明,mTORC1代理目标的选择可以在活动测量中引入偏差.

结论:

下游效应器的选择显著影响了对mTORC1激酶活性的评估.
研究人员必须仔细考虑用于量化mTORC1信号的具体目标,以避免有偏见的解释.
这项研究凸显了用于酶活性的代理标记物的复杂性,并强调了在多个目标上进行验证的必要性.

更多相关视频

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments

Measuring Attention and Visual Processing Speed by Model-based Analysis of Temporal-order Judgments

Published on: January 23, 2017

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

Published on: May 25, 2015

相关概念视频

GPCRs Regulate Adenylyl Cylase Activity

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...

IP3/DAG Signaling Pathway

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Transducer Mechanism: G Protein–Coupled Receptors

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...

GPCR Desensitization

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...